首页> 外文学位 >Toward Developing Pharmacokinetic Response Criteria to Chemoradiation in Head and Neck Cancer Patients Using Dynamic Contrast-Enhanced MRI.
【24h】

Toward Developing Pharmacokinetic Response Criteria to Chemoradiation in Head and Neck Cancer Patients Using Dynamic Contrast-Enhanced MRI.

机译:利用动态对比增强MRI制定针对头颈癌患者化学放疗的药代动力学反应标准。

获取原文
获取原文并翻译 | 示例

摘要

Purpose: The purpose of this study was to assess the feasibility of using dynamic contrast-enhanced MRI to monitor early treatment-induced changes in pharmacokinetic (PK) parameters in head and neck cancer patients. The intrinsic variability of three parameters (Ktrans, v e, and iAUC60) without treatment intervention was measured and compared to the treatment-induced variability.;Materials and Methods: Twenty patients were imaged while undergoing chemoradiation therapy (CRT) for head and neck malignancies. The imaging protocol included two baseline scans one week apart (B1, B2), and a third scan after 1-2 weeks of chemoradiation (ETX - early treatment). The images were acquired on a 1.5T scanner in the coronal plane with a temporal resolution of 10 sec. A population-averaged arterial input function was calculated from plasma concentration curves in both the left and the right carotids of each patient at each time point (B1, B2, ETX). The statistical significance of using a left/right AIF or a time-point-specific AIF was evaluated using Bland-Altman plots. To further ensure the correct calculation of PK parameters, the accuracy of the flip angles produced by the MR scanner was measured in phantoms and a volunteer. PK analysis was performed in iCAD (Nashua, NH) based on the modified Tofts model. This study focuses on two PK parameters used in the Tofts model (Ktrans, ve), and one semi-quantitative parameter that was also calculated in iCAD using an uptake integral approach (iAUC60). Ktrans, ve, and iAUC60 were averaged over regions of interest (ROIs), some of which covered primary tumors, and others of which covered known nodal metastases. Bland-Altman plots were used to describe the intrinsic variability in each parameter between the two baseline scans. The coefficient of repeatability (CR) between the baseline values was determined from the Bland-Altman plots and compared to the magnitude of the observed treatment-induced changes.;Results: The plasma parameters for the population-averaged AIF were a1 = 27.1135 kg/liter, a2 = 17.6486 kg/liter, m1 = 11.7525 min-1, and m2 = 0.2054 min -1. The use of a left- or right-sided AIF was determined to be unnecessary, as it did not give statistically different PK parameters than the population-averaged AIF. The use of a time-point-specific AIF was not necessary in most cases, though it may give more accurate results when Ktrans values are > 1 min-1. The flip angle tests revealed high inaccuracies at a flip angle of 5°, so flip angles ≤ 5° were not used in PK analysis. The intrinsic variability of Ktrans, ve, and iAUC60 was very high. For nodes, the CRs from the B1-B2 Bland-Altman plots were 0.725 min-1 for Ktrans, 0.315 for ve, and 18.15 mM-sec for iAUC60. The fractions of node ROIs which showed treatment-induced changes greater than the CR were 3 out of 14 for Ktrans, 3 out of 17 for ve, and 7 out of 17 for iAUC60. For primaries, the CRs were 1.385 min-1 for K trans, 0.305 for ve, and 62.85 mM-sec for iAUC60. The fractions of primary ROIs which showed treatment-induced changes greater than the CR were 0 out of 9 for Ktrans, 1 out of 11 for ve , and 2 out of 12 for iAUC60.;Conclusions: A population-averaged AIF for head and neck was generated that accounts for differences in right vs. left carotids, day-to-day AIF fluctuations, and treatment-induced AIF changes. It is not necessary to use a side-specific or a time-point-specific AIF. When Ktrans is greater than 1 min-1, PK parameter accuracy may be improved with the use of a time-point-specific AIF. Using the average AIF, large intrinsic fluctuations were observed in ROI-averaged values of Ktrans, ve, and iAUC60, making these parameters poor evaluators of early treatment response in head and neck cancer. Nodes were slightly more likely than primaries to show significant treatment-induced changes. Overall, the use of averaged MR-based PK parameters to assess early treatment response is limited and challenging. An analysis of voxel-based variability might be better suited to this task.
机译:目的:本研究的目的是评估在头颈癌患者中使用动态对比增强MRI监测早期治疗引起的药代动力学(PK)参数变化的可行性。测量了未经治疗干预的三个参数(Ktrans,v e和iAUC60)的固有变异性,并将其与治疗引起的变异性进行了比较。;材料与方法:对二十名患者进行了头颈部恶性肿瘤化学放疗(CRT)的成像。成像方案包括两次相隔一周的基线扫描(B1,B2),以及在放化疗1-2周后进行的第三次扫描(ETX-早期治疗)。图像在冠状平面的1.5T扫描仪上以10秒的时间分辨率获得。根据每个时间点(B1,B2,ETX)每个患者左,右颈动脉的血浆浓度曲线,计算出人群平均动脉输入函数。使用Bland-Altman图评估使用左/右AIF或特定于时间点的AIF的统计显着性。为了进一步确保正确计算PK参数,在幻像和志愿者中测量了MR扫描仪产生的翻转角的准确性。基于修改的Tofts模型,在iCAD(新罕布什尔州纳舒厄)中进行PK分析。这项研究的重点是在Tofts模型中使用的两个PK参数(Ktrans,ve)和在iCAD中也使用吸收积分法(iAUC60)计算的一个半定量参数。 Ktrans,ve和iAUC60在感兴趣区域(ROI)上取平均值,其中一些覆盖原发性肿瘤,而另一些覆盖已知的淋巴结转移。使用Bland-Altman图来描述两次基线扫描之间每个参数的内在变异性。根据Bland-Altman图确定基线值之间的重复性系数(CR),并与观察到的治疗引起的变化幅度进行比较。结果:人群平均AIF的血浆参数为a1 = 27.1135 kg /升,a2 = 17.6486千克/升,m1 = 11.7525 min-1,m2 = 0.2054 min -1。确定没有必要使用左侧或右侧AIF,因为它没有提供与总体平均AIF在统计上不同的PK参数。在大多数情况下,没有必要使用特定于时间点的AIF,尽管当Ktrans值> 1 min-1时,它可能会提供更准确的结果。翻转角测试显示,在5°的翻转角下存在很高的误差,因此PK分析中未使用≤5°的翻转角。 Ktrans,ve和iAUC60的内在变异性非常高。对于节点,来自B1-B2 Bland-Altman图的CR对于Ktrans为0.725 min-1,对于ve为0.315,对于iAUC60为18.15 mM-sec。显示出治疗引起的改变大于CR的结点ROI的分数,对于Ktrans,为14分之3,对于ve为17分之3,对于iAUC60为17分中的7分。对于原色,CR的CR值为1.385 min-1,ve的CR为0.305,iAUC60的CR为62.85 mM-sec。表现出治疗引起的变化大于CR的主要ROI的比例是,Ktrans的9中为0,ve的11中为1,iAUC60为12中的2,结论:人群的头颈部平均AIF产生的结果解释了右颈动脉和左颈动脉的差异,日常AIF波动以及治疗引起的AIF变化。不必使用特定于侧面或特定于时间点的AIF。当Ktrans大于1 min-1时,可以使用特定于时间点的AIF来提高PK参数的准确性。使用平均AIF,在Ktrans,ve和iAUC60的ROI平均值中观察到了较大的内在波动,这使得这些参数无法有效评估头颈部癌的早期治疗反应。淋巴结较原发癌更有可能出现明显的治疗引起的改变。总体而言,使用基于MR的平均PK参数来评估早期治疗反应是有限且具有挑战性的。基于体素的变异性分析可能更适合此任务。

著录项

  • 作者

    Onxley, Jennifer Dixon.;

  • 作者单位

    Duke University.;

  • 授予单位 Duke University.;
  • 学科 Health Sciences Radiology.;Health Sciences Oncology.
  • 学位 M.S.
  • 年度 2012
  • 页码 73 p.
  • 总页数 73
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号